Agenda

Session Introduction

Reshma L. Mahtani, DO

‍

HER2 or Not HER2? That is the Question

Michael Press, MD, PhD

‍

HER2: From Fear to Frontier in Early Breast Cancer

Kelly E. McCann, MD, PhD

‍

Audience Q&A and Panel Discussion

Reshma L. Mahtani, DO; Kelly E. McCann, MD, PhD; Michael Press, MD, PhD